DICAR/DICAR-JP exerts therapeutic effects in brain stroke via the miR-361-5p/PRMT1 pathway
DICAR/DICAR-JP has potential therapeutic benefits in stroke, which is mediated by the miR-361-5p/PRMT1 signaling pathway.
Authors
- Zhijun Yu (ORCID: https://orcid.org/0000-0003-4588-8800)
- Zifei Xiang
- Zheng Kuai (ORCID: https://orcid.org/0000-0003-1866-5564)
- Li Chen (ORCID: https://orcid.org/0000-0001-7670-8062)
- Aihua Jiang (ORCID: https://orcid.org/0009-0003-2592-4971)
- Qiong Yuan (ORCID: https://orcid.org/0009-0003-6825-711X)
- Lin Zhan (ORCID: https://orcid.org/0009-0008-7840-524X)
Institutions
- Fudan University (CN)
- Southwest Medical University (CN)
- Zhongshan Hospital (CN)
- Wuhan University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.3389/fphar.2025.1721188
- Primary Topic
- Cancer-related gene regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00